Question 1

What is the catalog number for AZD-9291 dimesylate?

Accepted Answer

The catalog number for AZD-9291 dimesylate is M16969.

Question 2

What sizes are available for AZD-9291 dimesylate?

Accepted Answer

AZD-9291 dimesylate is available in the following size(s): 1 g, 100 mg, 200 mg, 500 mg, Inquire.

Question 3

How many pack sizes does AZD-9291 dimesylate come in?

Accepted Answer

AZD-9291 dimesylate is available in 5 different pack sizes.

Question 4

Is AZD-9291 dimesylate in stock?

Accepted Answer

AZD-9291 dimesylate is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is AZD-9291 dimesylate used for?

Accepted Answer

A potent, selective, third-generation irreversible inhibitor of mutant EGFR with IC50s of 1/12/5 nM for L858R-T790M/L858R/L861Q respectively.

Question 6

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 7

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

Question 8

What is the recommended storage temperature after reconstitution?

Accepted Answer

Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.

AZD-9291 dimesylate

Product Specifications

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

BRCA1 (Breast Marker) (BRCA1/2985), CF405S conjugate, 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF647 conjugate, 0.1mg/mL

Human LDLR Antibody Pair Set

TIGIT / VSTM3 / VSIG9 (Immune Checkpoint for Cancer) (TIGIT/3106), CF405S conjugate, 0.1mg/mL

Bcl-X (Apoptosis Marker) (BCL2L1/1762), CF640R conjugate, 0.1mg/mL

Recombinant GPNMB Monoclonal Antibody